![](https://s3.amazonaws.com/cache.altmetric.com/policy/thumbnails/thumbnail-00553de1d01c29e89a0f5356f55b601778133b24779d2932c91daa0be764d944.jpg)
Sugammadex for the Recovery of Neuromuscular Blockade in Adult Patients: Clinical Effectiveness and Cost-Effectiveness - An Update
Cited by Canadian Agency for Drugs and Technologies in Health on
CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.